Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

NewCardio Inc

NWCI
Current price
Last closed
Company
ISIN US28257U1043
Sector Healthcare
Industry Medical Devices
Exchange OTCCE
Capitalization 49 722 USD
Yield for 12 month -100.00 %
1Y
3Y
5Y
10Y
15Y
NWCI
21.11.2021 - 28.11.2021

NewCardio, Inc., a cardiac diagnostic and services company, focuses on the research, development, and commercialization of proprietary software platform technology solutions for the non-invasive diagnosis and monitoring of cardiovascular disease (CVD), as well as the cardiac safety assessment of drugs under development. The company's technology platform provides real-time and 3-D analysis of the heart's electrical activity as detected at the body surface by standard 12-lead electrocardiogram (ECG) electrodes. Its developing products include QTinno, an automated cardiac safety solution that replaces the manual and/or semi-automated methodologies with algorithms that automatically measure, analyze, and report on the ECGs collected; and CardioBip, a mobile ECG transtelephonic system comprising a mobile ECG recording and transmitting device, and a Web enabled software which receives, processes, and analyzes the data. The company is also developing my3KG, a software application to provide a method to assess cardiac electrical activity in time and space. NewCardio, Inc. was founded in 2004 and is based in Branchburg, New Jersey. Address: PO Box 658, Branchburg, NJ, United States, 08853

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

1.25 USD

P/E ratio

Dividend Yield

Current Year

+257 399 USD

Last Year

Current Quarter

+9 883 USD

Last Quarter

+101 559 USD

Current Year

+105 103 USD

Last Year

Current Quarter

-17 578 USD

Last Quarter

+65 626 USD

Key Figures NWCI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -7 258 414 USD
Operating Margin TTM -15765.37 %
PE Ratio
Return On Assets TTM -224.19 %
PEG Ratio
Return On Equity TTM
Wall Street Target Price 1.25 USD
Revenue TTM 238 582 USD
Book Value -0.17 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -90 %
Dividend Yield
Gross Profit TTM 105 103 USD
Earnings per share
Diluted Eps TTM
Most Recent Quarter III 2011
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics NWCI

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History NWCI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation NWCI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.2084
Price Sales TTM 0.2084
Enterprise Value EBITDA -0.0076
Price Book MRQ

Financials NWCI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators NWCI

For 52 weeks

0.0001 USD
50 Day MA
Shares Short Prior Month
200 Day MA
Short Ratio
Shares Short
Short Percent